✦ LIBER ✦

Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia

✍ Scribed by Hagop M. Kantarjian; Craig Childs; Susan O'Brien; Yang Huh; Miloslav Beran; Jay Schachner; Charles Koller; Michael J. Keating

Book ID: 115683364
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 627 KB
Volume: 90
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(91)80164-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of fludarabine, a new adenine n

Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytoid variant of chronic lymphocytic leukemia

✍ Hagop M. Kantarjian; Craig Childs; Susan O'Brien; Yang Huh; Miloslav Beran; Jay 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 674 KB

The impact of initial fludarabine therap

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011)

✍ Solh, Melhem; Rai, Kanti R.; Peterson, Bercedis L.; Kolitz, Jonathan E.; Appelba 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 571 KB

Phase 2 study of a combined immunochemot

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia

✍ Schulz, H. 📂 Article 📅 2002 🏛 American Society of Hematology 🌐 English ⚖ 176 KB

Amifostine does not reduce the toxicity

Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia

✍ Francis J. Giles; Gary Guangping Shi; Jorge E. Cortes; Deborah Thomas; Anna R. K 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

A comparison of the efficacy and safety

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial

✍ Claire E. Dearden; Sue Richards; Monica Else; Daniel Catovsky; Peter Hillmen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract ## BACKGROUND: An oral formulation of fludarabine was introduced for use in chronic lymphocytic leukemia in 2001 following studies demonstrating the bioequivalence of a 40 mg/m^2^ oral dose with a 25 mg/m^2^ intravenous dose. We assessed retrospectively the efficacy of these two routes

Chemoimmunotherapy With Low-Dose Fludara

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia

✍ Foon, K. A.; Boyiadzis, M.; Land, S. R.; Marks, S.; Raptis, A.; Pietragallo, L.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 106 KB